News Releases

News Releases

Prometheus Biosciences to Participate at the Jefferies Healthcare Conference

May 26, 2022
SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc . (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of
Displaying 1 - 10 of 39